Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for PONV Prophylaxis in Head and Neck Surgery
NCT05134363Completed
- Sponsor
- Cairo University
- Start
- Aug 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Cairo University. Primary endpoint: Incidence of Postoperative Nausea and Vomiting at 24 hours. Started Aug 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT05134363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05134363.